News
Blue Bird Corporation , the leader in electric and low-emission school buses, showcases its latest zero- and ultra-low emission commercial vehicle platforms at the upcoming 2025 Advanced Clean ...
Mythics, LLC, an award-winning Oracle systems integrator, announced today that they have acquired Smart ERP Solutions, Inc. (SmartERP), a global enterprise software and consulting firm that focuses on ...
Business Insider CEO Barbara Peng sent out the following on Monday: I’m thrilled to share that Jeff Rabb is joining Business ...
KIITEE Phase 1 Results 2025 has been declared at kiitee.kiit.ac.in. The direct link to check is given below. The Kalinga Institute of Industrial Technology, KIIT, has declared the KIITEE 2025 ...
The Kalinga Institute of Industrial Technology has released the KIITEE 2025 Phase 1 results for its entrance exam. Candidates can now check their scores, subject-wise marks, and overall rank ...
BSEB Teacher Competency Test 2025: Check schedule for Phase 3, 4 and 5 here. (Representative image) Addressing a press conference, BSEB Chairman Anand Kishore announced that the third phase of the ...
Includes reviews of Roush Honda from DealerRater. Want to share your experience with this dealership? Jan was so kinda and very helpful with my new purchase! I would recommend reaching out to her ...
The U.S. Department of Health and Human Services is calling on companies to phase out all petroleum-based dyes by the end of next year, Secretary Robert F. Kennedy, Jr. announced Tuesday.
Bioxodes has stopped enrolling people in a phase 2a stroke study after hitting the safety and efficacy endpoints, positioning the Belgian biotech to power into a potentially registrational trial.
BSEB Teacher Competency Test 2025: The timetable for the Phase 3, 4, and 5 Teacher Competency Test 2025 has been released by the Bihar School Examination Board (BSEB) on April 26, 2025.
Besides Human Mixtard, the phase-out could impact its top brands in the Rs 5,000 crore insulin market including Actrapid, Insulatard, Insulin Detemir and Levemir and Xultophy — marketed mostly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results